TIMP3 and melanoma: In subsequent in vivo experiments, it was shown that recombinant adenoviral vector carrying the TIMP-3 gene sequence (RAdTIMP-3) when administered to mice with xenograft melanoma line A2058 effectively inhibited gelatinase activity and suppressed tumor growth by inducing apoptosis [152].